Last updated: July 2, 2023
Sponsor: Beijing Tiantan Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bone Marrow Disorder
Treatment
N/AClinical Study ID
NCT05939232
KY2023-011-02
Ages 6-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: X-ALD group:
- Meet the diagnostic criteria of X-ALD and supported by the results of genetic and verylong chain fatty acid (VLCFA) test;
- Age: 6 - 70 years old;
- Able to communicate normally, and complete the test of scale as instructed (confirmedby the field test of scale);
- Sign the informed consent. Carrier-control group: Healthy people who have no significant difference in age, sex and education comparing withthe X-ALD group, volunteer to participate in this study, could complete the test of scaleas instructed, and meet the following criteria:
- Eligible for asymptomatic carriers in genetic tests (preference of patient's motherand close relatives);
- Age: 6 - 70 years old, able to complete the test of scale as instructed (confirmed bythe field test of scale);
- No history of psychiatric diseases.
Exclusion
Exclusion Criteria:
- Other hereditary diseases;
- Other severe central nervous diseases;
- History of surgery of brain or eye;
- Psychiatric and psychological diseases, such as anxiety and depression;
- Metal foreign body or prosthesis in the human body (such as pacemaker and insulinpump), claustrophobia, and other MRI contraindications;
- History of surgery associated with gastrointestinal tract;
- No informed consent;
- Unable to tolerate MRI or eye related tests.
Study Design
Total Participants: 200
Study Start date:
July 20, 2023
Estimated Completion Date:
December 01, 2028
Study Description
Connect with a study center
Beijing Tiantan Hospital
Beijing, 100050
ChinaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.